We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SWTX SpringWorks Therapeutics Inc

1.74 (5.73%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,496,265
Bid Price 32.50
Ask Price 33.00
News -
Day High 32.45


52 Week Range


Day Low 28.67
Company Name Stock Ticker Symbol Market Type
SpringWorks Therapeutics Inc SWTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.74 5.73% 32.13 19:47:28
Open Price Low Price High Price Close Price Prev Close
30.14 28.67 32.45 31.90 30.39
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
23,361 1,496,265 $ 31.22 $ 46,718,222 - 18.00 - 34.16
Last Trade Time Type Quantity Stock Price Currency
19:44:01 12 $ 32.99 USD

SpringWorks Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2B 62.58M - 0 -277.42M -4.43 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SpringWorks Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SWTX Message Board. Create One! See More Posts on SWTX Message Board See More Message Board Posts

Historical SWTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week20.7533.50620.191926.222,904,02311.3854.84%
1 Month25.7833.50618.0024.011,391,7856.3524.63%
3 Months27.0933.50618.0024.04833,8225.0418.6%
6 Months27.3633.50618.0025.57707,5884.7717.43%
1 Year24.5334.1618.0026.45703,9037.6030.98%
3 Years66.1096.4813.6037.51597,614-33.97-51.39%
5 Years24.5096.4813.6037.89483,6287.6331.14%

SpringWorks Therapeutics Description

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |